⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31708151 | 0.85 | IGF1R (0.38) | — | |
| SCHEMBL30712086 | 0.82 | GABRP (0.43) | — | |
| SCHEMBL31708196 | 0.80 | NPC1 (0.43) | — | |
| SCHEMBL30712098 | 0.79 | HTR1D (0.39) | — | |
| SCHEMBL31708138 | 0.71 | SLC22A6 (0.44) | — | |
| SCHEMBL30712073 | 0.71 | ALOX5 (0.63) | — | |
| SCHEMBL19459867 | 0.71 | ALOX5 (0.63) | — | |
| SCHEMBL30712088 | 0.68 | PARP1 (0.51) | — | |
| SCHEMBL30276803 | 0.68 | NR4A2 (0.65) | — | |
| SCHEMBL19426095 | 0.67 | ALDH1A1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635492-A2 | TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS | Gilgamesh Pharmaceuticals, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |